Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Envista Holdings (NVST) Long-Term Debt Issuances (2020 - 2025)

Envista Holdings' quarterly Long-Term Debt Issuances came in at -$115.4 million in Q4 2025, up 6.94% quarter-over-quarter from -$124.0 million in Q4 2022.

Envista Holdings has reported Long-Term Debt Issuances for 3 years, with the latest figure at -$115.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to -$115.4 million; the trailing twelve-month figure through Dec 2025 stood at -$115.4 million (up 6.94% YoY), and the FY2023 full-year result was $500.2 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q4 2025 stood at -$115.4 million, up from -$124.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was -$115.4 million in Q4 2025, with the low at -$124.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 46.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 875.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 5.04 Mn
10 Envista Holdings 3.87 Bn 2.79 Bn 390.10 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -115.40 Mn
Dec 31, 2025 -115.40 Mn
Dec 31, 2022 -124.00 Mn
Dec 31, 2022 -124.00 Mn
Apr 3, 2020 249.80 Mn
Apr 3, 2020 249.80 Mn